FBXW7-AS1 and acute respiratory distress syndrome: To determine bioeffects of DEspR-inhibition, we analyzed ARDS patient whole blood with humanized anti-DEspR IgG4S228P antibody, hu6g8, added as ex vivo treatment for 17–20 h overnight with rotation to prevent aggregation.